Pregled bibliografske jedinice broj: 753591
The role of tramadol hydrochloride in treating rheumatic diseases (comparative approach)
The role of tramadol hydrochloride in treating rheumatic diseases (comparative approach) // International Journal of Tissue Reactions : experimental and clinical aspects 1997 ; 19 (1-2) : 21
Ženeva, Švicarska, 1997. (poster, međunarodna recenzija, sažetak, ostalo)
CROSBI ID: 753591 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The role of tramadol hydrochloride in treating rheumatic diseases (comparative approach)
Autori
Vlak, Tonko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
International Journal of Tissue Reactions : experimental and clinical aspects 1997 ; 19 (1-2) : 21
/ - , 1997
Skup
7th Interscience World Conference on Inflammation, Antirheumatics, Analgesics, Immunomodulators
Mjesto i datum
Ženeva, Švicarska, 19.05.1997. - 21.05.1997
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Rheumatoid arthritis; Tramadol
Sažetak
In order to evaluate the efficacy of tramadol hydrochloride ("Tramal" Grunental GMBH) in treatment rheumatic diseases, it has been administered to a group of 68 patients with rheumatic diseases (rheumatoid arthritis = 14 patients ; osteoarthritis of the knee and hip = 20 patients ; low back šain = 34 patients) receiving 50 milligrams tramadol hydrochloride twice a day during a 10-day treatment. The visual analogue scale (VAS) has been used in following the pain relief assessments during the therapy. The best analgesic effect of tramadol hydrochloride has been proved on the patients affected by the vertebrogen painful syndrome of lumbar spine. During the terapeutic treatment with tramadol hydrochloride 13 (19%) patients, mostly the elderly, experienced side effects, manifested as nausea and dry mouth. There were no side effects in the control group.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE